Blinatumomab in Treating Patients With B-cell Acute Lymphoblastic Leukemia With Minimal Residual Disease
Conditions
- Adult Acute Lymphoblastic Leukemia in Complete Remission
- B Acute Lymphoblastic Leukemia
- Minimal Residual Disease
- Philadelphia Chromosome Positive
Interventions
- BIOLOGICAL: Blinatumomab
- OTHER: Laboratory Biomarker Analysis
Sponsor
M.D. Anderson Cancer Center
Collaborators